TT, good points. A couple of observations / musings about a confirmatory study.
1. It would have quick recruitment (should take a day or three to get significant numbers and PCR test results to confirm are similarly quick). In essence this is a very easy study that would be cheap and quick.
2. Sites are already set up to do the study. Extension of ethics etc is a much easier path than starting from scratch. US data collection site for FDA already in place from the current data collection.
3. All the Australian Dx studies so far published showed insignificant difference between the training set results and those obtained in the subsequent double blind confirmatory studies. A good sign but not conclusive of course.
4. There is a gold standard test (PCR) to test the algorithm against, thus eliminating any clinician subjectiveness (which was the problem with the Dx US study).
Looking forward to the announcement.
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-202
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable